Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids

Computational and Structural Biotechnology Journal(2022)10.1016/j.csbj.2022.07.017Source: DataRank Database

Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids is a research paper published in Computational and Structural Biotechnology Journal (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.49)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Xing Tan,Tingyu Chu ORCID,Yanqin Huang ORCID,Amisha P. Rana ORCID,Nidhi Singh ORCID

Live enrichment

PubMed:35950190 PMC:PMC9352398 OpenAlex:https://openalex.org/W4285498548

National Institute of Allergy and Infectious Diseases

Grant: R01AI090155

National Institute of Allergy and Infectious Diseases

Grant: R01AI148560

National Institutes of Health

Grant: 5R01AI090155-05

The molecular basis of the epidemic blaKPC gene Klebsiella

National Institutes of Health

Grant: 5R01AI148560-05

Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs

National Institutes of Health

FWCI

0.49

Citation Percentile

0.5%

Citation Trend

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.csbj.2022.07.017

publisherhttps://doi.org/10.1016/j.csbj.2022.07.017

publisherhttps://api.elsevier.com/content/article/PII:S2001037022002975?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2001037022002975?httpAccept=text/plain

publisherhttps://spj.science.org/doi/pdf/10.1016/j.csbj.2022.07.017

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyVibrio bacteria research studies0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Klebsiella pneumoniaeCeftazidime/avibactamMicrobiologyCeftazidimeAntibioticsPlasmidAvibactamBiologyCarbapenemDrug resistanceAntibiotic resistanceBacteriaPseudomonas aeruginosaGeneEscherichia coliGeneticsHypervirulentAntibiotic ToleranceTranscriptomicCarbapenem-resistantTP248.13-248.65BiotechnologyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)